Board Meeting31 Oct 2026, 01:01 pm
Trident Texofab Board Meeting on Nov 5 to Approve Unaudited Financial Results
AI Summary
Trident Texofab Ltd has announced that its Board of Directors will convene on November 5, 2026, to consider and approve the un-audited financial results for the quarter and half-year ended September 30, 2026. In line with SEBI regulations, the trading window for the company's equity shares, which was closed from October 1, 2026, will reopen 48 hours after the results are publicly disclosed. This meeting is a routine procedural step for financial reporting and compliance.
Key Highlights
- Board meeting scheduled for November 5, 2026.
- To approve un-audited financial results for Q2/H1 FY27.
- Trading window to reopen 48 hours post-results announcement.
- Compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Price Impact
More from TTFL